logo

The Hidden Challenge of Weight Loss Jabs

Apr 27, 2026
Beyond the Jab Thumbnail
Weight loss injections—often referred to as GLP‑1 receptor agonists like semaglutide (Wegovy) or tirzepatide (Mounjaro)—have transformed the conversation around obesity management.

From Injection to Transformation: The Power of Ongoing Care

These medications mimic natural hormones to regulate appetite, blood sugar, and insulin, helping thousands achieve significant weight reduction. But a new study from the University of Cambridge reveals a critical truth: stopping these jabs can lead to rapid weight regain within just one year.

 

What the Research Shows

  • Participants regained 60% of the weight they lost within 52 weeks of stopping treatment.
  • By 60 weeks, weight regain plateaued at around 75% of the original loss, meaning only a quarter of the progress was sustained long‑term.
  • Experts warn that if the regained weight is mostly fat rather than lean muscle, patients could be “worse off than before” in terms of body composition.

This underscores a vital point: weight loss is not just about the medication—it’s about ongoing support, lifestyle changes, and personalized care.

Why Personalized Care Is Essential

While GLP‑1 medications are powerful tools, they are not a standalone solution. Sustainable transformation requires:

  • Medical guidance to monitor progress and adjust treatment.
  • Nutritional planning to maintain lean muscle and metabolic health.
  • Behavioral support to reinforce healthy habits and prevent relapse.

At Transcend Rejuvenation, we believe science works best when paired with human connection. That’s why we offer free consultations with medical professionals—so you can explore your options safely and confidently.